Ji et al. (2012) reported that COX-2 expressions were stronger in thyroid carcinoma than in thyroid adenomas and normal tissues and that the COX-2 expressions in thyroid carcinoma were correlated with the tumor type and tumor-node-metastasis (TNM) stage. Here, PTGS2 is linked to thyroid gland carcinoma.